Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Editor' summary: A paradigm shift in castration-resistant prostate cancer management.

Publication ,  Journal Article
De Nunzio, C; Amstrong, AJ; Van Oort, I; Dorff, T
Published in: Prostate Cancer Prostatic Dis
April 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

April 2022

Volume

25

Issue

4

Start / End Page

601 / 603

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Receptors, Androgen
  • Prostatic Neoplasms, Castration-Resistant
  • Male
  • Humans
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Nunzio, C., Amstrong, A. J., Van Oort, I., & Dorff, T. (2022). Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis, 25(4), 601–603. https://doi.org/10.1038/s41391-022-00574-x
De Nunzio, Cosimo, Andrew J. Amstrong, Inge Van Oort, and Tanya Dorff. “Editor' summary: A paradigm shift in castration-resistant prostate cancer management.Prostate Cancer Prostatic Dis 25, no. 4 (April 2022): 601–3. https://doi.org/10.1038/s41391-022-00574-x.
De Nunzio C, Amstrong AJ, Van Oort I, Dorff T. Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):601–3.
De Nunzio, Cosimo, et al. “Editor' summary: A paradigm shift in castration-resistant prostate cancer management.Prostate Cancer Prostatic Dis, vol. 25, no. 4, Apr. 2022, pp. 601–03. Pubmed, doi:10.1038/s41391-022-00574-x.
De Nunzio C, Amstrong AJ, Van Oort I, Dorff T. Editor' summary: A paradigm shift in castration-resistant prostate cancer management. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):601–603.

Published In

Prostate Cancer Prostatic Dis

DOI

EISSN

1476-5608

Publication Date

April 2022

Volume

25

Issue

4

Start / End Page

601 / 603

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Receptors, Androgen
  • Prostatic Neoplasms, Castration-Resistant
  • Male
  • Humans
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis